Ticker

6/recent/ticker-posts

Advertisement

Responsive Advertisement

United States Biopsy Market will be USD 14 Billion by 2025 - Renub Research

The biopsy is the procedure to collect the tissues or fluid from the area, which has grown abnormally over a period of time. The sample (tissue or fluid) is further examined through the microscope to check the presence of cancer. Different types of biopsy are done to know cancer, such as vacuum-assisted biopsy, fine-needle aspiration biopsy, and core needle biopsy. 



Liquid biopsies offer a secure and reliable way to collect samples, to treat invasively and to diagnose more rapidly, resulting in increased demand for these tools. It is a rapid process that usually involves simply drawing blood, extracting nucleic acids from the blood plasma, and amplifying molecular targets to allow the identified biomarkers. Increasing awareness of minimally invasive procedures, favorable government initiatives and the presence of an immense cancer population base are key drivers of market growth. United States Biopsy Market is predicted to surpass USD 14 Billion by the end of the year 2025.

The essential factors that will fuel the market growth are; the rise of an ageing population in the United States, continuous improvement of healthcare infrastructure, rising per capita health care expenditure, increasing per capita income, growing awareness about early detection of cancer by several screening including biopsy, improvement of diagnostic technologies, etc. Moreover, the rising incidence of cancer in the United States and increase of less invasive procedures during biopsy will further propel the United States biopsy market in the future course of time.

The major factors that fuel the United States liquid biopsy market are; increasing prevalence of different types of cancer, non-invasive techniques such as liquid biopsy tests are in more demand in United States, comfort of patient, detection of tumor in early stages, rising healthcare infrastructure, increasing per capita income and increasing awareness regarding liquid biopsy in United States.


About Us:

Renub Research is a Market Research and Consulting Company. We have more than 10 years of experience especially in international Business-to-Business Researches, Surveys, and Consulting. We provide a wide range of business research solutions that helps companies in making better business decisions. Our clients rely on our market analysis and data to make informed knowledgeable decisions. Our pertinent analysis helps consultants, bankers and executives to make informed and correct decisions.


Contact Us
Renub Research
Phone: +1-678-302-0700
Website: www.renub.com

Post a Comment

0 Comments